0001209191-19-061657.txt : 20191220
0001209191-19-061657.hdr.sgml : 20191220
20191220194453
ACCESSION NUMBER: 0001209191-19-061657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191219
FILED AS OF DATE: 20191220
DATE AS OF CHANGE: 20191220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Starling William N JR
CENTRAL INDEX KEY: 0001324130
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 191303213
MAIL ADDRESS:
STREET 1: 2300 BUCKSKIN ROAD
CITY: POCATELLO
STATE: ID
ZIP: 83201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX, INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX INC.
DATE OF NAME CHANGE: 20131210
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-19
0
0000876378
TRANSENTERIX, INC.
TRXC
0001324130
Starling William N JR
345 GOLDEN HILLS DRIVE
PORTOLA VALLEY
CA
94028
1
0
0
0
Common Stock
2019-12-19
4
S
0
3587
1.39
D
17983
I
See Footnote
Common Stock
2019-12-19
4
S
0
6015
1.44
D
11968
I
See Footnote
Common Stock
18134
I
See Footnote
Common Stock
131102
I
See Footnote
Common Stock
1568
D
Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
Reflects a reverse stock split of the Registrant's common stock at a ratio of one-for-thirteen with marketplace effectiveness on December 12, 2019 whereby the resulting fractional share was rounded up to the nearest whole share.
The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.44 to $1.445 inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Shares of Common Stock held by Synecor, L.L.C. Willam N. Starling is the chief executive officer of Synecor, L.L.C.
Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P.
/s/ Joshua Weingard attorney-in-fact for William N. Starling, Jr.
2019-12-20